Prostate Cancer
Novigenix Wins €1.8M EU Grant to Work With Cancer Biomarker Consortium
The Swiss cancer liquid biopsy firm will contribute its expertise and technologies including its AI-driven LITOSeek liquid biopsy platform.
Korea's IMBDx Explores NSCLC Therapy Guidance, Multi-Cancer Early Detection for Liquid Biopsy Tech
Premium
The company recently published data on its NGS-based pleural effusion liquid biopsy panel and is launching a large multimodal MCED study in Korea.
MDxHealth Q4 Revenues Rise 28 Percent
The firm's full-year 2024 revenues also rose 28 percent to $90.0 million, beating the Wall Street consensus estimate.
The firm said that its MyProstateScore 2.0 test delivers equivalent performance with samples collected at home or collected following digital rectal examination.
Veracyte Eyes Dropping IVD/Pharma Subsidiary in Europe As Growth Concentrates Among Clinical LDTs
Premium
Company officials lauded its core tests and shared news about launches planned for the upcoming year, including its minimal residual disease assay.